-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN CA0717341071-
BAUSCH HEALTH COS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol BVF
-
BAUSCH HEALTH COS INCBörse Börse BerlinEURSymbol BVF
-
BAUSCH HEALTH COS INCBörse Börse FrankfurtEURSymbol BVF
-
BAUSCH HEALTH COS INCBörse Börse MünchenEURSymbol BVF
-
BAUSCH HEALTH COS INCBörse Gettex System der Börse MünchenEURSymbol BVF
-
BAUSCH HEALTH COS INCBörse Börse DüsseldorfEURSymbol BVF
-
BAUSCH HEALTH COS INCBörse Quotrix System der Börse DüsseldorfEURSymbol BVF
-
BAUSCH HEALTH COS INCBörse Börse StuttgartEURSymbol BVF
-
Bausch Health CompaniesBörse NYSE New York Stock ExchangeISIN CA0717341071 WKN: A2JQ1XUSDSymbol BHC
-
ISIN CA0717341071 WKN: A2JQ1XCADSymbol BHC
-
MXN
-
EUR
-
ISIN CA0717341071
WKN A2JQ1X
Symbol BHC
Währung
USD
Börse
NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname
Bausch Health Companies Inc
Marktkapitalisierung
8.809.269.472 (+- 8%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
9.523.538.944 oder 8.095.000.000
Mitarbeiter
20.800 (+- 4%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
21.700 oder 19.900 Mitarbeiter
EBITDA 3.119.000.064
PEGRatio None
Buchwert 1.653
Zahlte zuletzt am 10.11.2010 eine Dividende von 1 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 28,04 USD +2,22%
Portrait der Bausch Health Companies Aktie
Das Unternehmen Bausch Health Companies Inc aus Kanada beschäftigt 20.800 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Chemie, Biotechnologie, Pharma tätig.
Das Unternehmen Bausch Health Companies Inc ist in ungefähr 23 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter VanEck Vectors Pharmaceutical ETF gewichtet Bausch Health Companies mit 3,46% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Bausch Health Companies Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Bausch Health Companies Inc am höchsten gewichtet ist Insgesamt in 23 ETFs enthalten
Dir gefallen die Informationen zu Bausch Health Companies?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Bausch Health Companies?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Bausch Health Companies?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Bausch Health Companies?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
82 News & Informationen zur Bausch Health Companies Aktie
Francis Chou Comments on Bausch Health
GuruFocus Article or News written by Sydnee Gatewood and the topic is about: Guru stock highlight
Francis Chou's Chou Associates Fund Semiannual 2021 Letter
GuruFocus Article or News written by Sydnee Gatewood and the topic is about: Discussion of markets and holdings
TSX Climbs To New Record Closing High
(RTTNews) – The Canadian stock market ended on a firm note on Friday, led by strong gains in energy and materials sections after crude oil and bul…
TSX Ends Weak As Investors Look For Directional Clues
(RTTNews) – The Canadian stock market ended weak on Thursday after languishing in the red right through the day's session. Losses in healthcare,…
Goldentree Asset Management Lp Buys Valaris, Frontier Communications Parent Inc, Noble Corp, Sells California Resources Corp, Eagle Bulk Shipping Inc, Denbury Inc
GuruFocus Article or News written by insider and the topic is about:
Professional Acne Treatment Market Worth $13,124.5 Million by 2030 says P&S Intelligence
/PRNewswire/ — From $6,298.9 million in 2020, the global professional acne treatment market value is predicted to reach $13,124.5 million by 2030, at a 7.6%…
$ 1.37 bn Growth in Epinephrine Autoinjector Market | Emerging Trends, Company Risk, and Key Executives | Technavio
/PRNewswire/ — The epinephrine autoinjector market is set to grow by $ 1.37 bn, progressing at a CAGR of over 7.84% during 2021-2025. The report offers an…
$ 1.37 bn Growth in Epinephrine Autoinjector Market | Emerging Trends, Company Risk, and Key Executives | Technavio
/PRNewswire/ — The epinephrine autoinjector market is set to grow by $ 1.37 bn, progressing at a CAGR of over 7.84% during 2021-2025. The report offers an…
$ 1.37 bn Growth in Epinephrine Autoinjector Market | Emerging Trends, Company Risk, and Key Executives | Technavio
/PRNewswire/ — The epinephrine autoinjector market is set to grow by $ 1.37 bn, progressing at a CAGR of over 7.84% during 2021-2025. The report offers an…
Global Dermatology Drugs Market to 2027 – Industry Analysis, Trends, Market Size, and Forecasts
/PRNewswire/ — The “Dermatology Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to…
Top 5 2nd-Quarter Trades of Larry Robbins' Firm
GuruFocus Article or News written by Graham Griffin and the topic is about: Several health care positions get a boost during the quarter
Greenleaf Trust Buys Huntington Bancshares Inc, Amerco Inc, NextEra Energy Inc, Sells Vanguard Intermediate-Term Corporate Bond ETF, iShares Agency Bond ETF, TCF Financial Corp
GuruFocus Article or News written by insider and the topic is about:
Fishman Jay A Ltd Buys Paysafe, AbbVie Inc, Bristol-Myers Squibb Company, Sells Macquarie Infrastructure Corp, Bausch Health Inc, Cisco Systems Inc
GuruFocus Article or News written by insider and the topic is about:
Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis – Forecast to 2026
DUBLIN, Aug. 19, 2021 /PRNewswire/ — The 'Global Atopic Dermatitis Drugs Market (2021-2026) by Drug Class, Route of Administration, Geography, Co…
Global Constipation Treatment Market Report 2021: Peripherally Acting Mu-Opioid Receptor Antagonists Segment to Record 5.7% CAGR
/PRNewswire/ — The
Smoking Cessation Aids Market to exceed US$ 64,032.30 million by 2028 – COVID-19 Impact and Global Analysis by The Insight Partners
/PRNewswire/ — According to our new research study on “Smoking Cessation Aids Market Forecast to 2028 – by Product, End User, and Geography,” the Smoking…
TSX Extends Losing Streak To 5th Session
(RTTNews) – The Canadian market, which recovered after weak start, moved along the flat line for much of the day's session on Wednesday, and event…
Canadian Market Roughly Flat In Cautious Trade; Healthcare Stocks Move Up
(RTTNews) – The Canadian market is flat Wednesday afternoon with stocks turning in a mixed performance as investors largely stay cautious and make…
The Worldwide Smoking Cessation Aids Industry is Expected to Reach $64 Billion in 2028
/PRNewswire/ — The “Smoking Cessation Aids Market Forecast to 2028 – COVID-19 Impact and Global Analysis by\ Product (Nicotine Replacement Therapy, Drugs,…
The Worldwide Smoking Cessation Aids Industry is Expected to Reach $64 Billion in 2028
/PRNewswire/ — The “Smoking Cessation Aids Market Forecast to 2028 – COVID-19 Impact and Global Analysis by\ Product (Nicotine Replacement Therapy, Drugs,…
The Worldwide Smoking Cessation Aids Industry is Expected to Reach $64 Billion in 2028
/PRNewswire/ — The “Smoking Cessation Aids Market Forecast to 2028 – COVID-19 Impact and Global Analysis by\ Product (Nicotine Replacement Therapy, Drugs,…
Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successfu…
Goldentree Asset Management Lp Buys Frontier Communications Parent Inc, Valaris, Builders FirstSource Inc, Sells California Resources Corp, Eagle Bulk Shipping Inc, Denbury Inc
GuruFocus Article or News written by insider and the topic is about:
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates
NEW YORK, Aug. 13, 2021 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch or the…
Respiratory Syncytial Virus (RSV) Market to Reach $4.2 Billion by 2027: CAGR 14.9%: Astute Analytica
/PRNewswire/ — As per the report “Global Respiratory Syncytial Virus Market – Industry Dynamics, Market Size, and Opportunity Forecast to 2027” published by…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. – BHC
NEW YORK, Aug. 11, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. . Such investors are advised to contact Robert S…. | August 12, 2021
Report 2021, Eyewear Market Size | Is Projected to Reach USD 178.95 Billion by 2026 with 5.7% CAGR
Eyewear Market Key Players Studied in this Report are Alcon (Part of Novartis AG), EssilorLuxottica, CooperVision, Johnson & Johnson Services, Inc Bausch…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. – BHC
NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Bausch Health Companies Inc. (“Bausch” or…
Global Depression Treatment Market (2020 to 2026) – Featuring Allergen, Bausch Health Companies and Lief Therapeutics Among Others
/PRNewswire/ — The
Global Depression Treatment Market (2020 To 2026) – Featuring Allergen, Bausch Health Companies And Lief Therapeutics Among Others
DUBLIN, Aug. 5, 2021 /PRNewswire/ — The
Why Bausch Health Companies Is Plunging Today
The turnaround isn't happening as fast as investors expected.
Bausch Health Companies, Inc. (BHC) CEO Joseph Papa on Q2 2021 Results – Earnings Call Transcript
Bausch Health Companies, Inc. (NYSE:BHC) Q2 2021 Earnings Conference Call August 03, 2021, 08:00 ET Company Participants Arthur Shannon – SVP & Head, IR & Global Communications…
Bausch Health Companies Inc. 2021 Q2 – Results – Earnings Call Presentation (NYSE:BHC)
The following slide deck was published by Bausch Health Companies Inc.
Bausch Health shares slide 6% premarket after surprise loss, says will seek IPO of Solta Medical business
Bausch Health Companies Inc. shares undefined fell 6% in premarket trade Tuesday, after the company posted a surprise loss in the second quarter, hurt by…
Bausch Health Companies EPS beats by $0.02, misses on revenue (NYSE:BHC)
Bausch Health Companies (BHC): Q2 Non-GAAP EPS of $0.97 beats by $0.02; GAAP EPS of -$1.66 misses by $1.37.Revenue of $2.1B (+26.5% Y/Y) misses by $20M.Adjusted EBITDA of $826M vs
Bausch Health Companies Inc. : Announces Second-Quarter 2021 Results
by Segment
For the Three Months Ended June 30, 2021 and 2020
Calculation of Organic Revenue for the Three Months Ended
June 30, 2021
June 30, 2020
Change in
Organic… | August 3, 2021
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Global Meibomian Gland Dysfunction Treatment Market Size to Grow at a CAGR of 9.2% from 2021 to 2030
The Global Meibomian Gland Dysfunction Treatment Market has been estimated to reach a value of USD 158.6 billion in 2021 and is projected to grow at a CAGR…
Earnings Scheduled For August 3, 2021
Companies Reporting Before The Bell
• Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter.
• Stellantis …